Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome.
Saved in:
| Title: | Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome. |
|---|---|
| Authors: | Peremiquel-Trillas P; Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Martínez JM; Faculty of Medicine, University of Barcelona, Barcelona, Spain.; Department of Gynaecology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Paytubi S; Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Frias-Gomez J; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Faculty of Medicine, University of Barcelona, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Pelegrina B; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Marin F; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain., Benavente Y; Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Ibáñez R; Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Barahona M; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain., Fernandez-Gonzalez S; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain., Cárdenas L; Gynaecologic Oncology Unit, Department of Gynaecology and Obstetrics, Hospital Universitari Dr. Josep Trueta, Girona, Spain., Taltavull A; Gynaecologic Oncology Unit, Department of Gynaecology and Obstetrics, Hospital Universitari Dr. Josep Trueta, Girona, Spain., Darder E; Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta Girona University Hospital, Girona, Spain., de Sanjosé S; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain.; ISGlobal, Barcelona, Spain., Widschwendter M; European Translational Oncology Prevention and Screening (EUTOPS) Institute, Universität Innsbruck, Innsbruck, Austria.; Institute for Biomedical Aging Research, Universität Innsbruck, Innsbruck, Austria.; Department of Women's Cancer, University College London, London, UK.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Matias-Guiu X; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain.; Department of Pathology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain., Bosch X; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Universitat Oberta de Catalunya, Barcelona, Spain., Pineda M; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain., Ponce J; Department of Gynaecology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain., Brunet J; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Gynaecologic Oncology Unit, Department of Gynaecology and Obstetrics, Hospital Universitari Dr. Josep Trueta, Girona, Spain., Alemany L; Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain., Costas L; Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.; Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain. |
| Source: | International journal of cancer [Int J Cancer] 2025 May 01; Vol. 156 (9), pp. 1791-1801. Date of Electronic Publication: 2025 Feb 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
